Breakthrough Cancer Research Donate

2019/2020 HRCI-HRB Joint Funding Scheme - Closed

The Health Research Chairties Group (formerly MRCG) comprises over 30 charities. Some of these participate in the HRCI/HRB Joint Funding Scheme. The scheme funds internationally competitive and innovative research in areas of strategic relevance to particular HRCI-registered research charities. 

The 2019-2020 Call is now CLOSED


The theme for our call is:



Opening Date:  1st October 2019

Closing Date:    8th November 2019 (5pm GMT)



Breakthrough Cancer Research is an Irish Medical Cancer Research Charity focused on funding research leading to new treatments for cancers which do not respond or are poorly served by available treatments. Breakthrough is committed to funding research to improve cancer care and outcomes and we ensure patient benefit is at the core of our efforts.  We emphasise clinically engaged projects, the role of the immune system and look for new interventions or approaches throughout the patient journey which will positively impact survival of patients with the toughest to cure cancers. 

This year both scientific and patient public initiative (PPI) reviewers will contribute to the overall scoring of the applications and awarding of the grants.  PPI in Research is defined as ‘Research carried out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them’. The PPI reviewers will assign a grade relating to appropriateness of the PPI involvement in the proposed research. When preparing your applications please consider, for example; (i) what PPI involvement do you have on your scientific and/or management teams, (ii) how have PPI members have contributed to the study design, preparation of the proposal, and (iii) what is your budget for PPI.  If you have any questions, please contact us.

Application Requirements:

Breakthrough invite research applications which:

  • Are patient focused and respond to a clinical need
  • Can demonstrate a path to translation into an intervention/treatment (even if over longer term)
  • Align with our Strategic Research Priorities


Funding Available:

Funding of up to €300,000 will be provided, for projects from 12 up to 36 months.  


Important Dates

8th November 2019 (5pm)

Deadline for Submission of Proposals to Breakthrough Cancer Research

November 2019 – January 2020

Charity Peer Review

10th- 28th February 2020

Right to Reply Phase

6th April 2020

HRB Application Deadline (via GEMs)

July 2020

Applicant Notification

November 2020

Research Project Start


Application Procedure

All applications must be submitted by email to by 8th November 2019, 5pm GMT.

Further Information

For further information on HRCI-HRB Joint Funding Scheme go to:

or contact Dr Frances Drummond via email on 


Related Documents to Download

© Site Designed by Granite Digital